[1] Song F, Jia W, Yao Y, et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes[J]. Clin Sci(Lond), 2007,112(12):599-606. [2] Kaneto H, Katakami N, Kawamori D, et al. Involvement of oxidative stress in the pathogenesis of diabetes[J]. Antioxid Redox Signal, 2007,9(3):355-366. [3] Bedard K,Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology[J]. Physiol Rev, 2007, 87(1): 245-313. [4] Riganti C. Diphenyleneiodonium Inhibits the cell redox metabolism and induces oxidative stress[J]. J Biol Chem, 2004, 279(46): 47726-47731. [5] Chang T, Wang R, Wu L, et al. Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells[J]. Free Radic Biol Med, 2005, 38(2): 286-293. [6] Chakraborti T, Das S, Mondal M, et al. Oxidant, mitochondria and calcium: an overview[J]. Cell Signal, 1999,11(2):77-85. [7] Leiter LA,Lewanczuk RZ. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition[J]. Am J Hypertens, 2005,18(1): 121-128. [8] Li JM, Mullen AM, Yun S, et al. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha[J]. Circ Res, 2002, 90(2): 143-150. [9] Xia L, Wang H, Goldberg HJ, et al. Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression[J]. Am J Physiol Renal Physiol, 2006, 290(2): F345-356. [10] Baumer AT. Phosphatidylinositol 3-kinase-dependent membrane recruitment of rac-1 and p47phox is critical for {alpha}-platelet-derived growth factor receptor-induced production of reactive oxygen species[J]. J Biol Chem, 2008, 283(12): 7864-7876. [11] Usatyuk PV. Regulation of hyperoxia-induced NADPH oxidase activation in human lung endothelial cells by the actin cytoskeleton and cortactin[J]. J Biol Chem, 2007, 282(32): 23284-23295. [12] Kitada M. translocation of glomerular p47phox and p67phox by protein kinase c-{beta} activation is required for oxidative stress in diabetic nephropathy[J]. Diabetes, 2003, 52(10): 2603-2614. [13] Xia L. Reactive oxygen species, PKC-beta1, and PKC-{zeta} mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells[J]. Am J Physiol Endocrinol Metab, 2007, 293(5): E1280-1288. [14] Denu JM,Tanner KG. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation[J]. Biochemistry, 1998,37(15):5633-5642. [15] Krejsa CM,Schieven GL. Impact of oxidative stress on signal transduction control by phosphotyrosine phosphatases[J]. Environ Health Perspect, 1998, 106(5): 1179-1184. [16] Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling[J]. Curr Opin Cell Biol, 2000,12(2):186-192. [17] Birnbaum MJ. Turning down insulin signaling[J]. J Clin Invest, 2001,108(3):655-659. [18] Taguchi A, Wartschow LM, White MF,et al. Brain IRS2 signaling coordinates life span and nutrient homeostasis[J]. Science, 2007,317(5836):369-372. [19] Wilson C, Vereshchagina N, Reynolds B, et al. Extracellular and subcellular regulation of the PI3K/Akt cassette: new mechanisms for controlling insulin and growth factor signalling[J]. Biochem Soc Trans, 2007,35(pt2):219-221. [20] Ye J. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle[J]. Endocr Metab Immune Disord Drug Targets, 2007,7(1):65-74. [21] Talior I, Yarkoni M, Bashan N, et al. Increased glucose upt ake promotes oxidative stress and PKC delta activation in adipocytes of obese, insulin-resistant mice[J]. Am J Physiol, 2003, 285(2): E295-E302. [22] JeBailey L, Wanono O, Niu W, et al. Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells[J]. Diabetes,2007,56(2):394-403. [23] 李兰芳,黄秀清,原慧萍,等.吡格列酮改善胰岛素抵抗状态下氧化应激水平及分子机制探讨[J].中国临床药理学与治疗学,2009,14(3):245-249. |